Ambu A/S (OTCMKTS:AMBBY) Posts Earnings Results

Ambu A/S (OTCMKTS:AMBBY) released its quarterly earnings results on Thursday. The company reported $0.14 earnings per share (EPS) for the quarter, Zacks reports. Ambu A/S had a return on equity of 8.49% and a net margin of 8.18%.

Ambu A/S Stock Performance

OTCMKTS:AMBBY traded up $1.50 during trading hours on Thursday, reaching $13.60. 1,000 shares of the company’s stock were exchanged, compared to its average volume of 45. Ambu A/S has a 1-year low of $8.54 and a 1-year high of $14.18. The company has a quick ratio of 1.69, a current ratio of 2.77 and a debt-to-equity ratio of 0.08. The firm has a market capitalization of $3.20 billion, a price-to-earnings ratio of 44.00 and a beta of 0.86. The company has a 50-day moving average of $11.10 and a 200 day moving average of $10.99.

Analyst Ratings Changes

Separately, UBS Group cut Ambu A/S from a “strong-buy” rating to a “hold” rating in a research note on Tuesday, September 15th. One analyst has rated the stock with a Hold rating. Based on data from MarketBeat, the stock has an average rating of “Hold”.

About Ambu A/S

Ambu A/S is a Danish medical technology company that develops, manufactures and markets single-use devices for hospitals and other healthcare providers. Its products are designed to support clinical procedures while reducing the need for cleaning, disinfection and reprocessing associated with reusable equipment.

The company’s portfolio includes single-use endoscopy systems, such as the aScope range of flexible endoscopes and related visualization equipment, as well as products for anesthesia, airway management, ventilation, resuscitation and patient monitoring.